Michael S. Cuffe - Feb 17, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: EVP and Chief Clinical Officer
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol: HCA
Transactions as of: Feb 17, 2023
Transactions value $: -$1,112,339
Form type: 4
Date filed: 2/22/2023, 07:01 PM
Previous filing: Feb 1, 2023
Next filing: Apr 26, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+12.2K	+58.4%	$0.00	33K	Feb 17, 2023	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$1.11M	-4.23K	-12.83%	$262.84	28.8K	Feb 17, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 29, 2020, the reporting person was granted 6,080 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Content

On January 29, 2020, the reporting person was granted 6,080 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.